West Pharmaceutical Services, Inc.

NYSE:WST Stock Report

Market Cap: US$22.3b

West Pharmaceutical Services Management

Management criteria checks 4/4

West Pharmaceutical Services' CEO is Eric Green, appointed in Apr 2015, has a tenure of 9.58 years. total yearly compensation is $9.40M, comprised of 12.1% salary and 87.9% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $51.70M. The average tenure of the management team and the board of directors is 4.5 years and 9.5 years respectively.

Key information

Eric Green

Chief executive officer

US$9.4m

Total compensation

CEO salary percentage12.1%
CEO tenure9.6yrs
CEO ownership0.2%
Management average tenure4.5yrs
Board average tenure9.5yrs

Recent management updates

Recent updates

West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next

Oct 27
West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next

West Pharma's Destocking Dilemma: Why Staying On The Sidelines Makes Sense

Oct 11

Getting In Cheap On West Pharmaceutical Services, Inc. (NYSE:WST) Is Unlikely

Sep 20
Getting In Cheap On West Pharmaceutical Services, Inc. (NYSE:WST) Is Unlikely

A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

Sep 02
A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 28
West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

West Pharmaceutical: Continued Destocking And A High Valuation Post Q2 Results (Rating Maintained)

Jul 25

Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?

Jul 15
Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?

We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt

Jun 27
We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt

Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

May 21
Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry

May 11

West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price

Mar 30
West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price

Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?

Mar 12
Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?

Why West Pharma Is Far From Done

Feb 28

West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price

Feb 20
West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price

West Pharmaceutical Services: Still Too Expensive After The Recent Drop

Feb 20

What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

Jan 10
What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

West Pharmaceutical: Great Business, Not So Great Valuation

Jan 08

What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You

Dec 18
What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

Nov 27
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

West Pharmaceutical Services: The Run Might Be Over

Oct 18

Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Sep 24
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

Aug 22
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics

Aug 08

What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?

Jun 26
What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?

West Pharmaceutical: Hard To Justify The Price

May 26

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

May 16
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?

Mar 20
At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?

West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture

Feb 28
West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture

West Pharmaceutical Q4 2022 Earnings Preview

Feb 15

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

Jan 31
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive

Dec 19

West Pharmaceutical declares $0.19 dividend

Dec 13

Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

Nov 29
Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

CEO Compensation Analysis

How has Eric Green's remuneration changed compared to West Pharmaceutical Services's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$500m

Jun 30 2024n/an/a

US$525m

Mar 31 2024n/an/a

US$569m

Dec 31 2023US$9mUS$1m

US$593m

Sep 30 2023n/an/a

US$559m

Jun 30 2023n/an/a

US$519m

Mar 31 2023n/an/a

US$552m

Dec 31 2022US$8mUS$1m

US$586m

Sep 30 2022n/an/a

US$631m

Jun 30 2022n/an/a

US$686m

Mar 31 2022n/an/a

US$684m

Dec 31 2021US$9mUS$1m

US$662m

Sep 30 2021n/an/a

US$613m

Jun 30 2021n/an/a

US$519m

Mar 31 2021n/an/a

US$423m

Dec 31 2020US$8mUS$989k

US$346m

Sep 30 2020n/an/a

US$312m

Jun 30 2020n/an/a

US$286m

Mar 31 2020n/an/a

US$261m

Dec 31 2019US$7mUS$936k

US$242m

Sep 30 2019n/an/a

US$230m

Jun 30 2019n/an/a

US$229m

Mar 31 2019n/an/a

US$219m

Dec 31 2018US$5mUS$880k

US$207m

Sep 30 2018n/an/a

US$155m

Jun 30 2018n/an/a

US$151m

Mar 31 2018n/an/a

US$133m

Dec 31 2017US$5mUS$824k

US$151m

Compensation vs Market: Eric's total compensation ($USD9.40M) is about average for companies of similar size in the US market ($USD12.91M).

Compensation vs Earnings: Eric's compensation has been consistent with company performance over the past year.


CEO

Eric Green (54 yo)

9.6yrs

Tenure

US$9,395,896

Compensation

Mr. Eric M. Green serves as Independent Director at Ecolab Inc. since December 08, 2022. He has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 24, 2015 and its President...


Leadership Team

NamePositionTenureCompensationOwnership
Eric Green
Non-Independent Chair of the Board9.6yrsUS$9.40m0.23%
$ 51.7m
Bernard Birkett
Senior VP & CFO6.4yrsUS$3.64m0.0095%
$ 2.1m
Silji Abraham
Senior VP & CTO3.9yrsUS$1.67m0.0040%
$ 880.9k
Kimberly MacKay
Senior VP3.9yrsUS$1.49m0.0019%
$ 419.3k
Cindy Reiss-Clark
Senior VP & Chief Commercial Officer5yrsUS$1.53m0.0067%
$ 1.5m
Chad Winters
VP, Chief Accounting Officer & Corporate Controller5.1yrsno data0.0018%
$ 403.6k
John Sweeney
Head of Investor Relationsno datano datano data
Michele Polinsky
Vice President of Global Communicationsno datano datano data
Rudy Poussot
Senior VP of Strategy & Corporate Developmentless than a yearno datano data
Annette Favorite
Chief Human Resources Officer & Senior VP9.1yrsUS$1.14m0.0090%
$ 2.0m
Kathy DePadua
Senior VP and Chief Quality & Regulatory Officer2.5yrsno datano data
Aileen Ruff-Patry
President of Contract Manufacturingless than a yearno datano data

4.5yrs

Average Tenure

54yo

Average Age

Experienced Management: WST's management team is considered experienced (4.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Eric Green
Non-Independent Chair of the Board9.5yrsUS$9.40m0.23%
$ 51.7m
Myla Lai-Goldman
Independent Director10.8yrsUS$359.35k0.024%
$ 5.3m
Robert Friel
Independent Director4.8yrsUS$330.66k0.0034%
$ 749.3k
Thomas Hofmann
Independent Director17.1yrsUS$390.35k0.059%
$ 13.2m
Mark Buthman
Independent Director13.8yrsUS$378.23k0.056%
$ 12.5m
Douglas Michels
Independent Director13.8yrsUS$377.01k0.059%
$ 13.2m
Paolo Pucci
Lead Independent Director8.2yrsUS$367.44k0.012%
$ 2.7m
Stephen Lockhart
Independent Director2.3yrsUS$331.46k0.0015%
$ 330.1k
William Feehery
Independent Director12.8yrsUS$362.83k0.040%
$ 9.0m
Deborah L. Keller
Independent Director7.4yrsUS$333.45kno data
Morihiro Sudo
Honorary Directorno datano datano data
Molly Joseph
Independent Director3.3yrsUS$321.43k0.00087%
$ 194.0k

9.5yrs

Average Tenure

63yo

Average Age

Experienced Board: WST's board of directors are considered experienced (9.5 years average tenure).